Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$59.88 USD
+1.18 (2.01%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $59.85 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
PRAX 59.88 +1.18(2.01%)
Will PRAX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRAX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PRAX
Praxis Stock Up as Epilepsy Candidate Shows Reduction in Seizures
Praxis Precision Medicines (PRAX) Upgraded to Buy: What Does It Mean for the Stock?
PRAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Praxis Precision Medicines, Inc. (PRAX) Reports Q2 Loss, Lags Revenue Estimates
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
Other News for PRAX
PRAX January 2025 Options Begin Trading
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
Philip Morris International To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Wednesday
Praxis Precision price target raised by $6 at Needham, here's why
Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations